NLS PHARMACEUTICS LTD *W EXP 02/02/202

NLS PHARMACEUTICS LTD *W EXP 02/02/202 is a security (CUSIP H57830111) tracked across SEC portfolio filings. 2 institutional managers reported $1K on Form 13F as of 2025-06-30.

Summary

Top institutional holders (Form 13F)

ManagerLocationValueShares
CLEAR STREET LLCNEW YORK, NY$1K57,762
CONCOURSE FINANCIAL GROUP SECURITIES, INC.BIRMINGHAM, AL0

More